Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Radiology

The Path to a Clear Answer: Imaging and Biopsy

At a Glance

Breast fibrosis is benign scar-like tissue that can look like cancer on mammograms, ultrasound, or MRI. A biopsy helps identify the tissue, but doctors must confirm that the pathology explains the imaging; a mismatch may require more sampling.

When your doctor sees an area of fibrosis (scar-like tissue) on a breast scan, it can be a source of significant stress. This is because fibrosis can “act” exactly like a tumor on imaging, creating shapes and shadows that are very similar to cancer without a tissue sample [1][2].

Why Imaging Can’t Tell the Difference

Fibrosis causes changes in the breast that mimic the “red flags” of cancer. Radiologists use a system called BI-RADS (Breast Imaging Reporting and Data System) to categorize these features. BI-RADS is a risk categorization system, not a final diagnosis. BI-RADS 1 or 2 generally need routine screening, and BI-RADS 3 findings usually require short-interval imaging. Fibrotic features often lead to a BI-RADS 4 (suspicious) or BI-RADS 5 (highly suggestive of malignancy) score, which triggers a biopsy [3].

  • Architectural Distortion: Fibrosis can pull and twist the surrounding breast tissue, creating a “starburst” pattern that looks like an invasive tumor on a mammogram [1].
  • Posterior Shadowing: On an ultrasound, dense fibrous tissue can block sound waves, creating a dark shadow behind it—a feature often seen in breast cancer [2].
  • Enhancement Patterns: On an MRI, some types of fibrosis can “light up” (enhance) with contrast, sometimes showing the same rapid uptake and “washout” seen in malignant tumors [4].

The Role of Biopsy

Because imaging alone is not definitive for suspicious lesions, a biopsy is the standard of care to confirm the area is benign. There are two primary types of image-guided biopsies used for fibrotic areas:

  1. Core Needle Biopsy (CNB): A hollow needle is used to take several thin “cores” of tissue. This is often used for larger masses visible on ultrasound [5].
  2. Vacuum-Assisted Biopsy (VAB): This uses a larger needle and gentle suction to collect more tissue through a single small incision. VAB is often utilized based on the lesion target and local expertise, particularly for architectural distortion or tiny calcium deposits (calcifications) [5][6].

What to Expect: During the procedure, your doctor will use local anesthetic to numb the area. You may feel pressure, but you should not feel sharp pain. The doctor will usually place a tiny metallic biopsy marker (or “clip”). This marks the spot for future mammograms, ensuring doctors know exactly where the biopsy was performed [7]. Expect some bruising and aching over the following days, and call your clinic if you experience worsening pain, heavy bleeding, or signs of infection.

Radiologic-Pathologic Concordance

The most critical step in your diagnosis is ensuring that the biopsy result “matches” what was seen on the scan. This is called radiologic-pathologic concordance [8].

  • Concordant Benign: The pathology shows a benign condition (like stromal fibrosis) that perfectly explains the suspicious imaging. For example, if the radiologist saw a firm, shadowed mass and the biopsy shows dense, thick collagen, the results “match” [9].
  • Discordant Benign: This is a potential red flag. It happens when the biopsy shows something benign, but that finding does not explain the suspicious imaging [8]. For instance, if the imaging looks like a 2cm tumor but the biopsy only shows “mild inflammation,” the doctor must assume the needle might have missed the real target.
  • Next Steps for Discordance: If a result is discordant, you should not simply wait and watch. Multidisciplinary review is required, and case-specific additional sampling—often a repeat biopsy or a surgical excision (removing the area)—is usually needed to ensure a cancer wasn’t missed [8][10].

Your Pathology Report Checklist

When you receive your pathology report, focus on asking your care team: “What exact diagnosis did my pathology report make, and does it explain my imaging?”

  • [ ] Specific Diagnosis: Does it say “stromal fibrosis”? Be aware that words like “sclerosing adenosis” and “PASH” (pseudoangiomatous stromal hyperplasia) are distinct benign entities, not interchangeable with fibrosis [4][P-85].
  • [ ] Target Confirmation: If the biopsy was for “calcifications,” does the report explicitly state that calcifications were found in the tissue sample [9]?
  • [ ] Atypia Status: Does the report mention any atypia (abnormal-looking cells)? Finding atypia within an area of fibrosis may change your future screening plan [11].
  • [ ] Concordance Statement: Does the report or a follow-up note from the radiologist explicitly state that the results are “concordant” [8]?

Common questions in this guide

What does breast fibrosis mean on a biopsy report?
Breast fibrosis, often called stromal fibrosis, is benign dense connective tissue that can look like cancer on imaging. The result is reassuring when the tissue finding explains the suspicious area and the care team confirms that the biopsy and imaging are concordant.
Why can breast fibrosis lead to a BI-RADS 4 or 5 rating?
Fibrosis can pull breast tissue into an architectural distortion, cast a shadow on ultrasound, or enhance on MRI, creating features that resemble cancer. A BI-RADS 4 or 5 rating means the imaging is suspicious, not that cancer has been proven, so a biopsy is often recommended.
How do core needle and vacuum-assisted breast biopsies differ?
A core needle biopsy removes several small cylinders of tissue with a hollow needle. A vacuum-assisted biopsy uses suction and a larger needle to collect more tissue through a small incision. The choice depends on the lesion, the imaging target, and local expertise.
Why is a marker clip placed after a breast biopsy?
A small metal marker shows exactly where the biopsy was performed and can be seen on future mammograms or other imaging. Post-biopsy imaging may confirm that the marker is centered in the area that was evaluated.
What does radiologic-pathologic concordance mean after a breast biopsy?
Radiologic-pathologic concordance means the biopsy result adequately explains the abnormality seen on imaging. A benign result such as stromal fibrosis is reassuring when it matches the imaging target; if it does not, the result may be called discordant and more sampling may be needed.
What happens if a benign breast biopsy is discordant with the imaging?
Ask the radiologist and treating team to review whether the sample accurately reached the area of concern. Further evaluation, often a repeat image-guided biopsy or surgical excision, may be recommended instead of simply observing the finding.
Can atypia in a breast fibrosis biopsy change my follow-up?
Yes. Atypia means that some cells look abnormal, and it can change future screening or risk-management recommendations. Ask whether your report mentions atypia or other proliferative changes and what follow-up is appropriate for you.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.My imaging showed architectural distortion; does the finding of 'stromal fibrosis' on my biopsy fully explain that specific feature?
  2. 2.Was a biopsy marker placed at the site, and did the post-biopsy imaging confirm it is in the exact center of the area we were worried about?
  3. 3.Why did you choose a core needle biopsy over a vacuum-assisted biopsy for this specific lesion?
  4. 4.If my results are 'discordant,' what are the next steps—a repeat biopsy or a surgical excision?
  5. 5.Does my pathology report show any 'atypia' or signs of 'proliferative' changes that might increase my future risk?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (11)
  1. 1

    Breast Fibromatosis: Radiologic-Pathologic Correlation.

    Winkler N, Peterson M, Factor R

    Journal of breast imaging 2021; (3(5)):597-602 doi:10.1093/jbi/wbab051.

    PMID: 38424943
  2. 2

    Stromal fibrosis: imaging features with diagnostic contribution of diffusion-weighted MRI.

    Yilmaz R, Bayramoglu Z, Kartal MG, et al.

    The British journal of radiology 2018; (91(1085)):20170706 doi:10.1259/bjr.20170706.

    PMID: 29388800
  3. 3

    Digital Mammography Stereotactic Biopsy versus Digital Breast Tomosynthesis-guided Biopsy: Differences in Biopsy Targets, Pathologic Results, and Discordance Rates.

    Rochat CJ, Baird GL, Lourenco AP

    Radiology 2020; (294(3)):518-527 doi:10.1148/radiol.2019191525.

    PMID: 31961261
  4. 4

    Fibrocystic Changes of the Breast: Radiologic-Pathologic Correlation of MRI.

    Choe AI, Kasales C, Mack J, et al.

    Journal of breast imaging 2022; (4(1)):48-55 doi:10.1093/jbi/wbab071.

    PMID: 38422411
  5. 5

    Image-guided biopsy of breast lesions-when to use what biopsy technique.

    Sanderink WBG, Camps-Herrero J, Athanasiou A, et al.

    Insights into imaging 2025; (16(1)):208 doi:10.1186/s13244-025-02084-5.

    PMID: 40996584
  6. 6

    Breast Microcalcifications: Diagnostic Outcomes According to Image-Guided Biopsy Method.

    Bae S, Yoon JH, Moon HJ, et al.

    Korean journal of radiology 2015; (16(5)):996-1005 doi:10.3348/kjr.2015.16.5.996.

    PMID: 26357494
  7. 7

    Advantages and Challenges of Using Breast Biopsy Markers.

    Alshafeiy TI, Matich A, Rochman CM, Harvey JA

    Journal of breast imaging 2022; (4(1)):78-95 doi:10.1093/jbi/wbab052.

    PMID: 38422410
  8. 8

    Radiologic-Pathologic Discordance After Image-Guided Breast Biopsy: A Systematic Review of Prevalence and Outcomes.

    Yincharoen P, Sharma CP, Tawanwongsri W

    Medical sciences (Basel, Switzerland) 2026; (14(2)) doi:10.3390/medsci14020229.

    PMID: 42201021
  9. 9

    Stromal Fibrosis of the Breast: A Spectrum of Benign to Malignant Imaging Appearances.

    Nassar L, Baassiri A, Salah F, et al.

    Radiology research and practice 2019; (2019()):5045908 doi:10.1155/2019/5045908.

    PMID: 30886748
  10. 10

    Role of ultrasound-guided vacuum-assisted breast biopsy in the management of radiologic-pathologic discordance: a retrospective single-centre study.

    Vatteroni G, Pinna G, Trimboli RM, et al.

    La Radiologia medica 2024; (129(10)):1454-1462 doi:10.1007/s11547-024-01864-1.

    PMID: 39102107
  11. 11

    Radial scars and complex sclerosing lesions on core needle biopsy of the breast: upgrade rates and long-term outcomes.

    Quinn EM, Dunne E, Flanagan F, et al.

    Breast cancer research and treatment 2020; (183(3)):677-682 doi:10.1007/s10549-020-05806-z.

    PMID: 32696314

This page explains how imaging and biopsy are used to evaluate breast fibrosis for informational purposes only and does not constitute medical advice. Your radiologist, pathologist, or breast specialist should interpret your results and recommend follow-up.

Get notified when new evidence is published on breast fibrosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.